Stand Up To Cancer (SU2C) has scheduled a second live primetime TV awareness and fundraising event for Friday, September 10 (8 PM EST/PST; 7 PM CT).
This will be almost exactly two years after the first event in September 2008 (OT, 9/25/08). Katie Couric, Diane Sawyer, and Brian Williams announced the upcoming show during individual live appearances on, respectively, CBS's “The Early Show,” ABC's “Good Morning America,” and NBC's “Today” show.
The three network evening news anchors will host the one-hour telecast and participated in a joint interview, which also aired on the morning shows.
ABC, CBS, and NBC are donating the hour of commercial-free time for the event, which will be telecast from Los Angeles and executive-produced as last time by Laura Ziskin, and will feature live performances and appearances by celebrities from film, television, and sports.
A news release notes that while the broadcast will honor the memory of those taken by the disease, it will focus on surviving cancer—on living a full life after being diagnosed.
HBO, Discovery Health, E!, MLB Network, and the Style Network will also carry the show this year, and other networks and cable channels are also expected to join the effort.
The program will include calls to donate through designated phone lines, as well as to the standup2cancer.org website; 100% of all public donations will go directly to cancer research, the organization promises.
“Our goal with this telecast is to not only continue to raise funds to accelerate promising research, but also show viewers how their money and individual action will make—and have already made—a difference,” Ms. Ziskin said.
The news release notes that the 2008 telecast helped raise more than $100 million, and more than $83 million has since been committed to five multidisciplinary “Dream Teams” of researchers from some 50 institutions, as well as to 13 young innovative scientists.
The American Association for Cancer Research is the scientific partner of Stand Up To Cancer and is responsible for administering the grants and providing scientific oversight in conjunction with the SU2C Scientific Advisory Committee, led by Nobel Laureate Phillip A. Sharp, PhD, Institute Professor at the David H. Koch Institute for Integrative Cancer Research at MIT.
Vice Chairs are Brian J. Druker, MD, Director of Oregon Health & Science University Knight Cancer Institute; and Arnold J. Levine, PhD, Professor at the Institute for Advanced Study and the Cancer Institute of New Jersey.
The SU2C funding model has fostered collaboration and innovation, and an often unprecedented sharing of ideas and pooling of resources across institutions. Less than one year after the announcement, all five Dream Teams have clinical trials planned or at various stages of development, the organization says.
The broadcast will highlight examples of the Dream Teams' progress to date—specifically in epigenetics, pancreatic cancer, the PI3K pathway, the circulating tumor cell chip, and breast cancer.
Coming in the next OT: Eric Rosenthal's investigation: “Play Nice & Collaborate, Stand Up (to Cancer) and Deliver–‘Shotgun Marriages” Merge & Morph Some Scientific Dream Teams.”